Similarly, elevated levels of SAs and ceramides have been observed in recently reported ALS cases associated with pathogenic variants in SPTLC2, another gene encoding a subunit of SPT [11, 12]. The gene discussed is AGXT; the disease is amyotrophic lateral sclerosis.